Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2363259 | 1.00 | TSHR (0.43) | TSHRNFKB1CYP2C19 | |
| SCHEMBL6492 | 0.89 | TSHR (0.39) | TSHRNFKB1CYP2C19 | |
| Hypochlorous Acid SCHEMBL15633664 | 0.86 | TSHR (0.40) | TSHRNFKB1CYP2C19 | |
| Hno SCHEMBL15954661 | 0.83 | TSHR (0.37) | TSHRNFKB1CYP2C19 | |
| SCHEMBL6567522 | 0.83 | TSHR (0.34) | TSHRNFKB1CYP2C19 | |
| Phosphoric Acid SCHEMBL6824270 | 0.82 | TSHR (0.38) | TSHRNFKB1CYP2C19 | |
| SCHEMBL5084504 | 0.81 | TSHR (0.35) | TSHRNFKB1CYP2C19 | |
| SCHEMBL2812394 | 0.80 | TSHR (0.41) | TSHRNFKB1CYP2C19 | |
| SCHEMBL6628615 | 0.79 | TSHR (0.34) | TSHRNFKB1CYP2C19 | |
| SCHEMBL5096697 | 0.79 | TSHR (0.34) | TSHRNFKB1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024033283-A1 | CONTINUOUS PROCESS FOR PRODUCING N-BUTYL (METH)ACRYLATE WITH A CATALYST RECIRCULATION SYSTEM | BASF SE (DE) | 2024-02-15 | — | — | WO | disclosed |
| WO-2024033279-A1 | CONTINUOUS METHOD FOR PRODUCING N-BUTYL(METH)ACRYLATE INCLUDING A CATALYST RECIRCULATION PROCESS | BASF SE (DE) | 2024-02-15 | — | — | WO | disclosed |
| US-20180037531-A1 | Inhibitor Combination for Lithium Salt-Catalyzed Transesterification Process and Method for Removing Lithium Salt | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-02-08 | — | — | US | disclosed |
| EP-3262129-A1 | METHOD FOR PRODUCING ISOSORBIDE ETHOXYLATE DIMETHACRYLATE | BASF SE (DE) | 2018-01-03 | — | — | EP | disclosed |
| EP-3262130-A1 | METHOD FOR PRODUCING ISOSORBIDE DIMETHACRYLATE | BASF SE (DE) | 2018-01-03 | — | — | EP | disclosed |
| US-9796650-B2 | Inhibitor combination for lithium salt-catalyzed transesterification process and method for removing lithium salt | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-10-24 | — | — | US | disclosed |
| EP-3227265-A1 | METHOD FOR PRODUCING HEONON(METH)ACRYLATE | BASF SE (DE) | 2017-10-11 | — | — | EP | disclosed |
| EP-3087049-A1 | INHIBITOR COMBINATION FOR LITHIUM SALT-CATALYZED TRANSESTERIFICATION PROCESS AND METHOD FOR REMOVING LITHIUM SALT | Dow Global Technologies Llc (US) | 2016-11-02 | — | — | EP | disclosed |
| US-20160297736-A1 | Inhibitor Combination for Lithium Salt-Catalyzed Transesterification Process and Method for Removing Lithium Salt | DOW GLOBAL TECHNOLOGIES LLC | 2016-10-13 | — | — | US | disclosed |
| US-9447201-B2 | Polymerization inhibitor composition and method of inhibiting polymerization of distillable monomers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-09-20 | — | — | US | disclosed |
| EP-1517942-A1 | (METH)ACRYLIC ESTERS OF POLYALKOXYLATED GLYCERINE | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-30 | — | — | EP | disclosed |
| EP-1516008-A1 | (METH)ACRYLIC ESTERS OF POLYALKOXYLATED TRIMETHYLOLPROPANE | BASF AKTIENGESELLSCHAFT (DE) | 2005-03-23 | — | — | EP | disclosed |
| WO-2004108795-A1 | (METH)ACRYLIC ESTER FOR ALKYLENYLENE GLYCOL AND THE USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-16 | — | — | WO | disclosed |
| WO-2004087790-A2 | MIXTURES OF POLYALKOXYLATED TRIMETHYLOLPROPANE (METH)ACRYLATE | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-14 | — | — | WO | disclosed |
| WO-2004050596-A1 | METHOD FOR THE RECTIFYING SEPARATION OF LIQUIDS CONTAINING (METH)ACRYLIC MONOMERS IN A RECTIFICATION COLUMN | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-17 | — | — | WO | disclosed |
| WO-2004048585-A2 | ENZYMATIC SYNTHESIS OF POLYOL ACRYLATES | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-10 | — | — | WO | disclosed |
| US-6740528-B2 | MONITORING REACTIVE IONS IN SAMPLE; OBTAIN SAMPLE, INCUBATE WITH MODULATOR OF IONIC ACTIVITY, ANALYZE WITH ELECTRON SPIN RESONANCE, COUNT REACTIVE IONS | HAKUTO CO., LTD. (JP) | 2004-05-25 | — | — | US | disclosed |
| WO-2003104301-A1 | (METH)ACRYLIC ESTERS OF POLYALKOXYLATED GLYCERINE | BASF AKTIENGESELLSCHAFT (DE) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003104300-A1 | (METH)ACRYLIC ESTERS OF POLYALKOXYLATED TRIMETHYLOLPROPANE | BASF AKTIENGESELLSCHAFT (DE) | 2003-12-18 | — | — | WO | disclosed |
| US-20020048820-A1 | Method for measuring concentration of stable free radical compound | HAKUTO CO., LTD. | 2002-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160297736-A1 | Inhibitor Combination for Lithium Salt-Catalyzed Transesterification Process and Method for Removing Lithium Salt | ADH1C, ADH1A, MAP2K1 | TSHR 3806/4885NFKB1 427/4885CYP2C19 711/4885 |
| US-20180037531-A1 | Inhibitor Combination for Lithium Salt-Catalyzed Transesterification Process and Method for Removing Lithium Salt | ADH1C, ADH1A, MAP2K1 | TSHR 3806/4885NFKB1 427/4885CYP2C19 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.